Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Adalimumab/brodalumab

Erythema elevatum diutinum and paradoxical exacerbation of psoriasis plaque: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Al-Gburi S, et al. Erythema elevatum diutinum - A Possible IgA-Derived Reaction under a Therapy with Adalimumab. [German]. Aktuelle Dermatologie 47: 207-210, No. 5, May 2021. Available from: URL: http://doi.org/10.1055/a-1421-2614 [German; summarised from a translation] Al-Gburi S, et al. Erythema elevatum diutinum - A Possible IgA-Derived Reaction under a Therapy with Adalimumab. [German]. Aktuelle Dermatologie 47: 207-210, No. 5, May 2021. Available from: URL: http://​doi.​org/​10.​1055/​a-1421-2614 [German; summarised from a translation]
Metadaten
Titel
Adalimumab/brodalumab
Erythema elevatum diutinum and paradoxical exacerbation of psoriasis plaque: case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-98951-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Apixaban

Case report

Brigatinib